Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Industry News

Related Searches:

Filter by:

July 30, 2010
Charles River Laboratories and WuXi PharmaTech, Inc. have decided to terminate their previously announced acquisition agreement.   Read More »
July 30, 2010
PPD, Inc. has expanded its cGMP lab testing services into Wayne, PA, to expand its services in the northeastern U.S.   Read More »
July 30, 2010
Harmony Labs has established a department focused on innovation and new product development.   Read More »
July 29, 2010
Quintiles is relocating its European headquarters to Green Park, Reading, England, which is located 30 minutes from Heathrow Airport.   Read More »
July 29, 2010
ATMI, Inc. has completed a two-year, multi-million dollar expansion of its Bloomington, MN manufacturing facility.   Read More »
July 27, 2010
QPS Holdings, LLC has completed its acquisition of Xendo Drug Development BV (XDD).   Read More »
July 27, 2010
Colorcon, Inc. has acquired India-based Pharmaceutical Coatings Pvt. Ltd., which includes the company's full product portfolio and a new facility in Goa that is currently under construction.   Read More »
July 19, 2010
Combined specialty chemicals company to reach nearly half a billion in sales.   Read More »
July 16, 2010
LyoTechnica, LLC has launched as a contract drug development services provider for injectable pharmaceuticals.   Read More »
July 16, 2010
Mary Foster, Pharm.D., vice president of Quality at Catalent, has been elected chair of the United States Pharmacopeia (USP) Packaging, Storage and Distribution Expert Committee for the 2010-2015 USP cycle.   Read More »
July 16, 2010
ICON has opened a purpose-built clinical pharmacology unit in the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK.   Read More »
July 15, 2010
Merck KGaA has completed its acquisition of Millipore Corp. for approximately $7.0 billion.   Read More »
July 15, 2010
Mylan, Inc. has plans to acquire Bioniche Pharma Holdings Ltd., a global injectable pharmaceutical company, for $550 million in cash.   Read More »
July 13, 2010
Human Genome Sciences, Inc. and Lonza entered an agreement for the commercial supply of Benlysta (belimumab), which is currently under regulatory review in the U.S. and EU as a potential treatment for systemic lupus erythematosus (SLE).   Read More »
July 13, 2010
Integrated DNA Technologies (IDT) has signed a three-year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On